What is the Share Price of Astec Lifesciences Ltd?

Astec Lifesciences Ltd share price is ₹765.75 As on 11 October, 2025|22:46

Home
>
Stocks
>
Astec Lifesciences Ltd

Astec Lifesciences Ltd Share Price

Q: What is the Market Cap of Astec Lifesciences Ltd?

The Market Cap of Astec Lifesciences Ltd is ₹1,706 As on 11 October, 2025|22:46

Q: What is PE Ratio of Astec Lifesciences Ltd?

The P/E ratio of Astec Lifesciences Ltd is 0 As on 11 October, 2025|22:46

Q: What is PB Ratio of Astec Lifesciences Ltd?

The PB ratio of Astec Lifesciences Ltd is 7.29 As on 11 October, 2025|22:46

₹ 765.75 +2.15 (0.28%)
Updated on 11-10-2025 8:25 AM

Stock Rating

Pros 1

Cons 8

Astec Lifesciences Ltd Price Performance

Day's Low
₹760.5

Day's High
₹775.45

₹ 765.75

52-w low
₹628.32

52-w high
₹1,251.34

765.75

Day's open
₹798.55
Previous close
₹763.599976
VWAP
₹767.01
Lower price band
₹612.6
Upper price band
₹918.9

Today's Market Action

The last traded share price of Astec Lifesciences Ltd was 765.75 up by 0.28% on the NSE. Its last traded stock price on BSE was 764.25 down by -0.95%. The total volume of shares on NSE and BSE combined was 12,860 shares. Its total combined turnover was Rs 0.99 crores.

Astec Lifesciences Ltd Medium and Long Term Market Action

Astec Lifesciences Ltd hit a 52-week high of 1,251.34 on 07-01-2025 and a 52-week low of 628.32 on 09-05-2025. The stock price of Astec Lifesciences Ltd is down by -10% over the last one month. It is down by -31.01% over the last one year. Don't forget to check the full stock price history in the table below.

Astec Lifesciences Ltd Fundamentals

Market Cap (Cr): 1706
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Astec Lifesciences Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Astec Lifesciences Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Astec Lifesciences Ltd

Data not available.

Astec Lifesciences Ltd FAQ's

What is Share Price of Astec Lifesciences Ltd?

What is the Market Cap of Astec Lifesciences Ltd?

What is PE Ratio of Astec Lifesciences Ltd?

What is PB Ratio of Astec Lifesciences Ltd?

What is the CAGR of Astec Lifesciences Ltd?

How to Buy Astec Lifesciences Ltd Share?

Can I buy Astec Lifesciences Ltd from Samco?

How do I buy Astec Lifesciences Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Strong Working Capital Cycle
The company has a great working capital cycle of 0 days which results in lower investments in working capital and higher asset turnover. This reduces capital requirement of the business and drives RoE and cash flow generation positively. This is extremely positive for long term shareholders of the business.

Cons

Momentum Strength
The stock is currently exhibiting weak momentum, & is showing weak relative strength.
Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Poor Cash Flow Conversion
The business has very poor cash conversion ratio of only -1000.00% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
Negative operating earnings and interest coverage
The company has a negative operating earnings and a negative Interest coverage ratio of -0.24 times which implies that the company has no operating earnings to pay for interest which is currently being paid out of capital and/or other income. This is extremely negative for shareholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Capital Intensive Business
The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.83. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
High Debt
The company has a very high debt to equity ratio of 2.36. Considering the fact that the business carries a high quantum of debt, equity shareholders shall carry higher risk in the business in case of an adverse interest rate cycle or downturn in economic cycle.

Valuation Analysis

Margin of safety
(11/10/2025)

103

Margin of Safety Index: High

0% People are bullish about Astec Lifesciences Ltd

0 % People are bearish about Astec Lifesciences Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %